Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Intranasal adipose-derived stem cells mitigate cuprizone-induced demyelination in mouse corpus callosum by modulating oligodendrocyte and microglial marker expression: histological and ultrastructural insights.

Mohamed NM., Mekawy MAERA., Shaker SM., Hamam GG.

Animal Study on Neuroinflammation, published in J Mol Histol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Mol Histol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41055799
DOI
10.1007/s10735-025-10615-z

Abstract (original English)

The corpus callosum is exposed to many degenerative disorders, such as multiple sclerosis (MS), which results in impaired communication between the two cerebral hemispheres. In contrast to stem cells of other origins, adipose-derived mesenchymal stem cells (ADMSCs) are efficiently obtained. The intranasal route is a new emerging noninvasive, easily available route for drug administration. To evaluate the effects of intranasal administration of ADMSCs on a cuprizone induced demyelinated corpus callosum in a mouse model of MS with reference to the role of oligodendrocytes and microglia. To establish a model of demyelination, mice were fed a cuprizone-rich diet. After 4 weeks, ADMSCs were administered intranasally, and the mice were subsequently sacrificed two weeks later. The corpora callosa were collected and subjected to hematoxylin and eosin (H&E), immunohistochemical staining for oligodendrocyte precursor cells and microglia, transmission electron microscopic examination, and histomorphometric studies. Intranasally administered ADMSCs ameliorated the histopathological features of cuprizone induced demyelination. ADMSCs prevented myelin loss, increased the number of oligodendrocyte precursor cells, and decreased the abundance of active microglia. ADMSCs have beneficial effects on preserving the histopathological structure and function of the corpus callosum in mice with demyel

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsCuprizoneCorpus CallosumMicrogliaDemyelinating DiseasesMiceOligodendrogliaAdministration, IntranasalBiomarkersDisease Models, Animal

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research